FDASIA Legislation Moves to Vote in Senate
| Posted: 26 June 2012
By Alexander Gaffney
The Food and Drug Administration Safety and Innovation Act (FDASIA), a massive piece of legislation aimed at renewing industry funding provisions for the US Food and Drug Administration (FDA) and making a number of regulatory changes at the agency, is on pace for approval on Tuesday, 26 June 2010.
In a vote to end debate—known as a Cloture Motion—on Monday, 89 Senators voted in favor of the motion while just three Senators—Richard Burr (R-NC), Bernie Sanders (I-VT) and Rand Paul (R-KY)—voted against the motion. Eight Senators were not present for the motion and did not vote.
The Hill’s Floor Action Blog reports the measure is still subject to “several hours of post-cloture debate on the bill,” but based on the Senate’s earlier near-unanimous approval of the bill, passage seems all but assured.
After approval in the Senate, the bill, which has already been approved in the House of Representatives, would go to President Barack Obama for his signature. The current pace of legislation indicates the legislation would likely be signed into law by Obama in early July 2012, with the law coming into effect in October 2012 when the previous user fee acts expire.
Senate: U.S. Senate Roll Call Votes 112th Congress - 2nd Session
The Hill - Tuesday: FDA in the Senate, maritime security in the House
The Pink Sheet - FDASIA Primed For Final Senate Vote After Cloture Motion Passes
Modern Healthcare - FDA user-fee legislation moves toward final vote